Premalignant  ||| S:0 E:13 ||| JJ
conditions  ||| S:13 E:24 ||| NNS
of  ||| S:24 E:27 ||| IN
the  ||| S:27 E:31 ||| DT
small  ||| S:31 E:37 ||| JJ
bowel  ||| S:37 E:43 ||| JJ
Small  ||| S:43 E:49 ||| JJ
intestinal  ||| S:49 E:60 ||| JJ
dysplastic  ||| S:60 E:71 ||| JJ
lesions  ||| S:71 E:79 ||| NNS
are  ||| S:79 E:83 ||| VBP
rare  ||| S:83 E:88 ||| JJ
and  ||| S:88 E:92 ||| CC
difficult  ||| S:92 E:102 ||| JJ
to  ||| S:102 E:105 ||| TO
detect  ||| S:105 E:112 ||| VB
before  ||| S:112 E:119 ||| IN
they  ||| S:119 E:124 ||| PRP
progress  ||| S:124 E:133 ||| VBP
to  ||| S:133 E:136 ||| TO
cancer ||| S:136 E:142 ||| NN
.  ||| S:142 E:144 ||| .
New  ||| S:144 E:148 ||| JJ
investigative  ||| S:148 E:162 ||| JJ
modalities ||| S:162 E:172 ||| NN
,  ||| S:172 E:174 ||| ,
such  ||| S:174 E:179 ||| JJ
as  ||| S:179 E:182 ||| IN
capsule  ||| S:182 E:190 ||| JJ
endoscopy  ||| S:190 E:200 ||| NN
and  ||| S:200 E:204 ||| CC
doubleballoon  ||| S:204 E:218 ||| JJ
enteroscopy ||| S:218 E:229 ||| NN
,  ||| S:229 E:231 ||| ,
are  ||| S:231 E:235 ||| VBP
very  ||| S:235 E:240 ||| RB
promising  ||| S:240 E:250 ||| VBG
in  ||| S:250 E:253 ||| IN
search  ||| S:253 E:260 ||| NN
for  ||| S:260 E:264 ||| IN
premalignant  ||| S:264 E:277 ||| JJ
lesions ||| S:277 E:284 ||| NNS
.  ||| S:284 E:286 ||| .
Screening  ||| S:286 E:296 ||| VBG
patients  ||| S:296 E:305 ||| NNS
at  ||| S:305 E:308 ||| IN
high-risk  ||| S:308 E:318 ||| JJ
for  ||| S:318 E:322 ||| IN
small  ||| S:322 E:328 ||| JJ
bowel  ||| S:328 E:334 ||| JJ
neoplasia  ||| S:334 E:344 ||| NN
is  ||| S:344 E:347 ||| VBZ
the  ||| S:347 E:351 ||| DT
only  ||| S:351 E:356 ||| JJ
sensible  ||| S:356 E:365 ||| JJ
approach ||| S:365 E:373 ||| NN
.  ||| S:373 E:375 ||| .
Duodenal  ||| S:375 E:384 ||| JJ
adenoma  ||| S:384 E:392 ||| NN
represents  ||| S:392 E:403 ||| VBZ
the  ||| S:403 E:407 ||| DT
most  ||| S:407 E:412 ||| RBS
easily  ||| S:412 E:419 ||| RB
accessible  ||| S:419 E:430 ||| JJ
tumors  ||| S:430 E:437 ||| NNS
with  ||| S:437 E:442 ||| IN
the  ||| S:442 E:446 ||| DT
possibility  ||| S:446 E:458 ||| NN
of  ||| S:458 E:461 ||| IN
curative  ||| S:461 E:470 ||| JJ
endoscopic  ||| S:470 E:481 ||| JJ
resection ||| S:481 E:490 ||| NN
.  ||| S:490 E:492 ||| .
Due  ||| S:492 E:496 ||| JJ
to  ||| S:496 E:499 ||| TO
the  ||| S:499 E:503 ||| DT
strong  ||| S:503 E:510 ||| JJ
association  ||| S:510 E:522 ||| NN
of  ||| S:522 E:525 ||| IN
the  ||| S:525 E:529 ||| DT
small  ||| S:529 E:535 ||| JJ
bowel  ||| S:535 E:541 ||| NN
and  ||| S:541 E:545 ||| CC
colonic  ||| S:545 E:553 ||| JJ
adenomas ||| S:553 E:561 ||| NN
,  ||| S:561 E:563 ||| ,
it  ||| S:563 E:566 ||| PRP
is  ||| S:566 E:569 ||| VBZ
always  ||| S:569 E:576 ||| RB
necessary  ||| S:576 E:586 ||| JJ
to  ||| S:586 E:589 ||| TO
perform  ||| S:589 E:597 ||| VB
colonoscopy ||| S:597 E:608 ||| NNS
.  ||| S:608 E:610 ||| .
In  ||| S:610 E:613 ||| IN
young  ||| S:613 E:619 ||| JJ
patients ||| S:619 E:627 ||| NNS
,  ||| S:627 E:629 ||| ,
the  ||| S:629 E:633 ||| DT
exclusion  ||| S:633 E:643 ||| NN
of  ||| S:643 E:646 ||| IN
familial  ||| S:646 E:655 ||| JJ
polyposis  ||| S:655 E:665 ||| NN
by  ||| S:665 E:668 ||| IN
genetic  ||| S:668 E:676 ||| JJ
testing  ||| S:676 E:684 ||| NN
is  ||| S:684 E:687 ||| VBZ
always  ||| S:687 E:694 ||| RB
mandatory ||| S:694 E:703 ||| JJ
.  ||| S:703 E:705 ||| .
Patients  ||| S:705 E:714 ||| NNS
with  ||| S:714 E:719 ||| IN
celiac  ||| S:719 E:726 ||| JJ
disease  ||| S:726 E:734 ||| NN
are  ||| S:734 E:738 ||| VBP
especially  ||| S:738 E:749 ||| RB
at  ||| S:749 E:752 ||| IN
risk  ||| S:752 E:757 ||| NN
of  ||| S:757 E:760 ||| IN
developing  ||| S:760 E:771 ||| VBG
nonHodgkins  ||| S:771 E:783 ||| JJ
lymphomas  ||| S:783 E:793 ||| NN
and  ||| S:793 E:797 ||| CC
adenocarcinomas ||| S:797 E:812 ||| NN
.  ||| S:812 E:814 ||| .
There  ||| S:814 E:820 ||| EX
is  ||| S:820 E:823 ||| VBZ
a  ||| S:823 E:825 ||| DT
high-risk  ||| S:825 E:835 ||| JJ
of  ||| S:835 E:838 ||| IN
ampuloma  ||| S:838 E:847 ||| NN
and  ||| S:847 E:851 ||| CC
other  ||| S:851 E:857 ||| JJ
adenomas  ||| S:857 E:866 ||| NN
in  ||| S:866 E:869 ||| IN
patients  ||| S:869 E:878 ||| NNS
with  ||| S:878 E:883 ||| IN
familial  ||| S:883 E:892 ||| JJ
adenomatous  ||| S:892 E:904 ||| JJ
polyposis ||| S:904 E:913 ||| NN
.  ||| S:913 E:915 ||| .
Patients  ||| S:915 E:924 ||| NNS
with  ||| S:924 E:929 ||| IN
prolonged  ||| S:929 E:939 ||| JJ
and  ||| S:939 E:943 ||| CC
complicated  ||| S:943 E:955 ||| JJ
course  ||| S:955 E:962 ||| NN
of  ||| S:962 E:965 ||| IN
Crohns  ||| S:965 E:972 ||| NNP
disease ||| S:972 E:979 ||| NN
,  ||| S:979 E:981 ||| ,
Peutzâ€Š ||| S:981 E:987 ||| NNP
Jeghers  ||| S:987 E:995 ||| NNP
syndrome  ||| S:995 E:1004 ||| NN
and  ||| S:1004 E:1008 ||| CC
patients  ||| S:1008 E:1017 ||| NNS
with  ||| S:1017 E:1022 ||| IN
ileoanal  ||| S:1022 E:1031 ||| JJ
pouch  ||| S:1031 E:1037 ||| NNS
have  ||| S:1037 E:1042 ||| VBP
higher  ||| S:1042 E:1049 ||| JJR
risk  ||| S:1049 E:1054 ||| NN
of  ||| S:1054 E:1057 ||| IN
adenocarcinoma  ||| S:1057 E:1072 ||| NN
of  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
small  ||| S:1079 E:1085 ||| JJ
intestine ||| S:1085 E:1094 ||| NN
.  ||| S:1094 E:1096 ||| .
